Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT) | MicrobiomeTrials← Back to trialsNCT04737720
Intravenous ACP-501 for Familial LCAT Deficiency (rhLCAT)
CompletedOBSERVATIONAL
Trial Details
Start: 2013-01-24Est. Completion: 2013-12-12
Enrollment target: 1 participants Locations- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
LCAT Deficiency
The purpose of the LCAT (Lecithin cholesterol acyl transferase) Natural History Study (LCAT NHS) is to help identify peo…
Philadelphia, United StatesEst. completion Aug 2027
To Determine Bioequivalence Under Fed Conditions
The purpose of this study is to compare the bioavailability of Par Lisinopril 40 mg Tablets and IPR Pharmaceuticals, Inc…
Baltimore, United StatesCompleted Oct 1999